Key result
Suboptimal DES deployment is linked to very late stent thrombosis up to 3 years post-implantation.
Why the study?
Suboptimal drug-eluting stent deployment may be associated with very late stent thrombosis beyond the traditional time frame of subacute thrombosis.
Does suboptimal drug-eluting stent deployment lead to very late stent thrombosis?
Case Report (n=1)
Does suboptimal drug-eluting stent deployment lead to very late stent thrombosis?
Suboptimal drug-eluting stent deployment may lead to very late stent thrombosis even years after the traditional subacute timeframe.
We report the case of a 55-year-old man who underwent coronary angiography in 2004 for early angina following anterior ST-elevation myocardial infarction. Angiography disclosed a critical stenosis in the proximal left anterior descending artery and significant stenoses in the right coronary artery and first obtuse marginal branch, treated with two paclitaxel-eluting stents and a sirolimus-eluting stent, respectively. After completion of a six-month thienopyridine course and while still being on lifelong aspirin, in 2007 he was readmitted for lateral ST-elevation myocardial infarction: angiography revealed stent thrombosis beginning at the proximal edge of the sirolimus-eluting stent implanted in the first obtuse marginal branch. Intravascular ultrasound was performed after thrombectomy but before balloon dilation showing suboptimal stent expansion and a thrombus partially adhering to the sirolimus-eluting stent. The procedure was then successfully completed with the implantation of another sirolimus-eluting stent. This clinical vignette suggests that suboptimal drug-eluting stent deployment may be associated with stent thrombosis well after the traditional time frame of subacute thrombosis.
No takes yet. Share an insight, caveat, or question.
Bollati et al. (2008) conducted a case report in Very late stent thrombosis (n=1). Suboptimal drug-eluting stent deployment was evaluated on Stent thrombosis. Suboptimal drug-eluting stent deployment may be associated with stent thrombosis well after the traditional time frame of subacute thrombosis, as seen in a patient 3 years post-implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: